Scott Wilson Curtis - Net Worth and Insider Trading
Scott Wilson Curtis Net Worth
The estimated net worth of Scott Wilson Curtis is at least $29,500 dollars as of 2024-11-08. Scott Wilson Curtis is the Senior Officer of Antibe Therapeutics Inc and owns about 100,000 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $29,500. Details can be seen in Scott Wilson Curtis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Wilson Curtis has not made any transactions after 2022-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott Wilson Curtis
Scott Wilson Curtis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Wilson Curtis owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .
Click here to see the complete history of Scott Wilson Curtis’s form 4 insider trades.
Insider Ownership Summary of Scott Wilson Curtis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ATE | Antibe Therapeutics Inc | 2022-11-15 | Senior Officer |
Scott Wilson Curtis Latest Holdings Summary
Scott Wilson Curtis currently owns a total of 1 stock. Scott Wilson Curtis owns 100,000 shares of Antibe Therapeutics Inc (TSX:ATE) as of November 15, 2022, with a value of $29,500.
Latest Holdings of Scott Wilson Curtis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:ATE | Antibe Therapeutics Inc | 2022-11-15 | 100,000 | 0.30 | 29,500 |
Holding Weightings of Scott Wilson Curtis
Scott Wilson Curtis Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Wilson Curtis has made a total of 9 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 7 buys and 2 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 20,000 shares on November 15, 2022, which cost Scott Wilson Curtis around $10,000.
Insider Trading History of Scott Wilson Curtis
- 1
Scott Wilson Curtis Trading Performance
GuruFocus tracks the stock performance after each of Scott Wilson Curtis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Wilson Curtis is -26.23%. GuruFocus also compares Scott Wilson Curtis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Wilson Curtis within 3 months outperforms 1 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott Wilson Curtis's insider trading performs compared to the benchmark.
Performance of Scott Wilson Curtis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.97 | | | | | |
| Relative Return to S&P 500(%) | -13.27 | | | | | |
Scott Wilson Curtis Ownership Network
Ownership Network List of Scott Wilson Curtis
Ownership Network Relation of Scott Wilson Curtis
Scott Wilson Curtis Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
Scott Wilson Curtis is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Daniel Marcel Legault .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
Scott Wilson Curtis Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Wilson Curtis. Currently GuruFocus does not have mailing address information for Scott Wilson Curtis.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
